Glucagon-Like Peptide-1 (GLP-1) receptor agonists are medicines indicated for the treatment of diabetes and for weight management in patients living with obesity or overweight with weight-related health conditions.
Public interest around these medicines, mostly around their use for weight-loss, has grown considerably in the last years. From academic and medical discussions to social media, from gossip to celebrity endorsements, GLP-1s are everywhere.
Join our Instagram LIVE with Dr. Bart Van der Schueren, EMA expert, endocrinologist and obesity specialist.
English (UK) 
Nederlands (België) 
Français de Belgique